Publication & Citation Trends
Most Cited Works
Publications
54 total
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China PDF
Cited by 195
OpenAlex
Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD PDF
Cited by 290
OpenAlex
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study PDF
Cited by 254
OpenAlex
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients PDF
Cited by 274
OpenAlex
Roxadustat (FG-4592) PDF
Cited by 246
OpenAlex
Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans PDF
Cited by 420
OpenAlex
Sulfation of L-Selectin Ligands by an HEV-Restricted Sulfotransferase Regulates Lymphocyte Homing to Lymph Nodes PDF
Cited by 161
OpenAlex
Vascular Endothelial Junction-associated Molecule, a Novel Member of the Immunoglobulin Superfamily, Is Localized to Intercellular Boundaries of Endothelial Cells PDF
Cited by 231
OpenAlex
Research Topics
Glycosylation and Glycoproteins Research
(23)
Cell Adhesion Molecules Research
(17)
Carbohydrate Chemistry and Synthesis
(13)
Proteoglycans and glycosaminoglycans research
(13)
Erythropoietin and Anemia Treatment
(9)
Frequent Co-Authors
Affiliations
Roche (Switzerland)
Roche (United States)
Westchester Medical Center
Yahoo (United Kingdom)
University of California, San Francisco